Paul N. Cheng
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
PEG-BCT-100 and Canavanine Synergistically Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer.
Journal: Cancer research communications
Published: August 14, 2024
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults.
Journal: Frontiers in oncology
Published: September 18, 2023
Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury.
Journal: Experimental neurology
Published: May 28, 2021
Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells.
Journal: Oxidative medicine and cellular longevity
Published: January 14, 2021
Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial-mesenchymal transition.
Journal: Scientific reports
Published: January 30, 2019
Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma.
Journal: Oncogenesis
Published: November 08, 2018
Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
Journal: Respiratory research
Published: September 29, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026